This story (one of five we reviewed on this study) summarizes the findings of a recent study into the potential of benefits of tai chi for patients suffering from fibromyalgia. Though somewhat longer than all but one of the other stories under review, the story provides only a surface look into the merits of the research and the circumstances of the condition.
A study like this will have so many people reading the coverage that it is important for reporters to fully explain the study’s limitations and the context around the condition and its possible therapies.
The story does not mention costs.
The story does not attempt to quantify benefits. Readers are left to make their own assumptions about what percentage of fibromyalgia patients in the US might benefit from tai chi classes.
The story does not identify any possible harms. It is difficult to imagine that twice-weekly tai chi, like any other form of moderate exercise, would be harmful, but, at a minimum, the story could have reported upon the study’s adverse events registry. The NEJM authors clearly state: "No adverse events were noted during the study interventions." The study did not consider worse muscle soreness to be an adverse event so long as it resolved before 3 days’ time, so we don’t know how much of that occurred in either arm of the study. So why not drop in a line about the lack of adverse events? Wouldn’t a reader be interested that this exercise appears safe?
The results publicized here are based on a small study of 66 fibromyalgia patients who were followed for a few months. The story does not discuss any of the limitations associated with a study of this nature. In addition, the story does not include any information about the group of patients who received wellness education training followed by gentle stretching instead of tai chi, so there is no point of comparison.
The story cites a questionable statistic about the scope of problem. Citing the National Fibromyalgia Association, the story says there are approximately 10 million sufferers of the condition in the U.S. It would have been more appropriate to rely on a number from an disinterested government source. (The National Institutes of Health estimates 5 million as the disease prevalence among adults over 18.)
The story does cite the opinions of a researcher who wrote an accompanying article in the journal. More outside voices would have been a nice addition. This criterion is barely satisfactory.
Very brief mention is given to existing alternatives, such as exercise, sleep techniques and medication, but no discussion of the track record of how well the alternative methods work.
Readers are left to make their own assumptions about the availability of tai chi classes in their communities. More problematic is that the story does not provide any detail about the style or rigor of the tai chi classes (aside from the fact that the classes last an hour), making it difficult for a patient, or health care advisor, to make an informed decision as to how to proceed.
The story explains that doctors routinely recommend exercise as one method of treatment for fibromyalgia patients, but with limited success. So in that sense, the story does undercut some of the novelty of the study’s findings. An excellent question for the researchers would have been: What is it that potentially makes tai chi a better form of exercise for this condition?
The story is based on an study appearing in the New England Journal of Medicine. The writer did contact the lead author and another researcher for quotes.
Systematic, Criteria-Driven
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like